Differences in HPRT mutant frequency among middle-aged Flemish women in association with area of residence and blood lead levels

Biomarkers were measured in residents of Wilrijk and Hoboken, industrial suburbs of the city of Antwerp, and of Peer, a rural municipality in Flanders, Belgium. Persons with known occupational exposures to toxic compounds or commuting over long distances were excluded. Here, we report the hypoxanthi...

Full description

Saved in:
Bibliographic Details
Published inBiomarkers Vol. 9; no. 1; pp. 71 - 84
Main Authors Van Larebeke, Nicolas, Koppen, Gudrun, Nelen, Vera, Schoeters, Greet, Van Loon, Herman, Albering, Harma, Riga, Louk, Vlietinck, Robert, Kleinjans, Jos
Format Journal Article
LanguageEnglish
Published London Informa UK Ltd 01.01.2004
Taylor & Francis
Subjects
Online AccessGet full text
ISSN0963-7486
1354-750X
1465-3478
1366-5804
DOI10.1080/13547500310001652160

Cover

Loading…
Abstract Biomarkers were measured in residents of Wilrijk and Hoboken, industrial suburbs of the city of Antwerp, and of Peer, a rural municipality in Flanders, Belgium. Persons with known occupational exposures to toxic compounds or commuting over long distances were excluded. Here, we report the hypoxanthine phosphoribosyltransferase gene (HPRT) variant frequencies for 99 non-smoking women aged 50-65 years. HPRT values above the detection limit (Vfpos values) were observed for 43 subjects (21 from Peer, 22 from Antwerp). The median (10th to 90th percentiles) HPRT variant frequency (Vfpos) in peripheral lymphocytes was 9.59 (3.44-56.99) for Peer and 3.57 (1.57-13.96) for Antwerp. The Vfpos value was significantly higher in Peer than in Antwerp, both in terms of crude data (p=0.011) and after correction for age, level of education, smoking status, serum level of selenium and body mass index through analysis of covariance (p=0.011). For the total study population, serum lead concentration showed a non-significant positive correlation with lnVfpos. In addition, subjects with a blood lead concentration above the median tended to have higher Vfpos values (9.45×10−6 for 'high' group versus 5.21×10−6 for 'low' group; p=0.077 after correction for confounding). Subjects with a serum selenium level above the median tended to have lower Vfpos values (4.99×10−6 for 'high' group versus 9.83×10−6 for 'low' group; p=0.051 after correction for confounding). These data are consistent with an indirect genotoxic effect of lead and with an antimutagenic effect of selenium.
AbstractList Biomarkers were measured in residents of Wilrijk and Hoboken, industrial suburbs of the city of Antwerp, and of Peer, a rural municipality in Flanders, Belgium. Persons with known occupational exposures to toxic compounds or commuting over long distances were excluded. Here, we report the hypoxanthine phosphoribosyltransferase gene (HPRT) variant frequencies for 99 non-smoking women aged 50-65 years. HPRT values above the detection limit (V fpos values) were observed for 43 subjects (21 from Peer, 22 from Antwerp). The median (10th to 90th percentiles) HPRT variant frequency (V fpos ) in peripheral lymphocytes was 9.59 (3.44-56.99) for Peer and 3.57 (1.57-13.96) for Antwerp. The V fpos value was significantly higher in Peer than in Antwerp, both in terms of crude data (p=0.011) and after correction for age, level of education, smoking status, serum level of selenium and body mass index through analysis of covariance (p=0.011). For the total study population, serum lead concentration showed a non-significant positive correlation with lnV fpos . In addition, subjects with a blood lead concentration above the median tended to have higher V fpos values (9.45×10 −6 for 'high' group versus 5.21×10 −6 for 'low' group; p=0.077 after correction for confounding). Subjects with a serum selenium level above the median tended to have lower V fpos values (4.99×10 −6 for 'high' group versus 9.83×10 −6 for 'low' group; p=0.051 after correction for confounding). These data are consistent with an indirect genotoxic effect of lead and with an antimutagenic effect of selenium.
Biomarkers were measured in residents of Wilrijk and Hoboken, industrial suburbs of the city of Antwerp, and of Peer, a rural municipality in Flanders, Belgium. Persons with known occupational exposures to toxic compounds or commuting over long distances were excluded. Here, we report the hypoxanthine phosphoribosyltransferase gene (HPRT) variant frequencies for 99 non-smoking women aged 50-65 years. HPRT values above the detection limit (Vfpos values) were observed for 43 subjects (21 from Peer, 22 from Antwerp). The median (10th to 90th percentiles) HPRT variant frequency (Vfpos) in peripheral lymphocytes was 9.59 (3.44-56.99) for Peer and 3.57 (1.57-13.96) for Antwerp. The Vfpos value was significantly higher in Peer than in Antwerp, both in terms of crude data (p=0.011) and after correction for age, level of education, smoking status, serum level of selenium and body mass index through analysis of covariance (p=0.011). For the total study population, serum lead concentration showed a non-significant positive correlation with lnVfpos. In addition, subjects with a blood lead concentration above the median tended to have higher Vfpos values (9.45×10−6 for 'high' group versus 5.21×10−6 for 'low' group; p=0.077 after correction for confounding). Subjects with a serum selenium level above the median tended to have lower Vfpos values (4.99×10−6 for 'high' group versus 9.83×10−6 for 'low' group; p=0.051 after correction for confounding). These data are consistent with an indirect genotoxic effect of lead and with an antimutagenic effect of selenium.
Biomarkers were measured in residents of Wilrijk and Hoboken, industrial suburbs of the city of Antwerp, and of Peer, a rural municipality in Flanders, Belgium. Persons with known occupational exposures to toxic compounds or commuting over long distances were excluded. Here, we report the hypoxanthine phosphoribosyltransferase gene (HPRT) variant frequencies for 99 non-smoking women aged 50-65 years. HPRT values above the detection limit (V(fpos) values) were observed for 43 subjects (21 from Peer, 22 from Antwerp). The median (10th to 90th percentiles) HPRT variant frequency (V(fpos)) in peripheral lymphocytes was 9.59 (3.44-56.99) for Peer and 3.57 (1.57-13.96) for Antwerp. The V(fpos) value was significantly higher in Peer than in Antwerp, both in terms of crude data (p=0.011) and after correction for age, level of education, smoking status, serum level of selenium and body mass index through analysis of covariance (p=0.011). For the total study population, serum lead concentration showed a non-significant positive correlation with lnV(fpos). In addition, subjects with a blood lead concentration above the median tended to have higher V(fpos) values (9.45x10(-6) for 'high' group versus 5.21x10(-6) for 'low' group; p=0.077 after correction for confounding). Subjects with a serum selenium level above the median tended to have lower V(fpos) values (4.99x10(-6) for 'high' group versus 9.83x10(-6) for 'low' group; p=0.051 after correction for confounding). These data are consistent with an indirect genotoxic effect of lead and with an antimutagenic effect of selenium.
Biomarkers were measured in residents of Wilrijk and Hoboken, industrial suburbs of the city of Antwerp, and of Peer, a rural municipality in Flanders, Belgium. Persons with known occupational exposures to toxic compounds or commuting over long distances were excluded. Here, we report the hypoxanthine phosphoribosyltransferase gene (HPRT) variant frequencies for 99 non-smoking women aged 50-65 years. HPRT values above the detection limit (V sub(fpos) values) were observed for 43 subjects (21 from Peer, 22 from Antwerp). The median (10th to 90th percentiles) HPRT variant frequency (V sub(fpos)) in peripheral lymphocytes was 9.59 (3.44-56.99) for Peer and 3.57 (1.57-13.96) for Antwerp. The V sub(fpos) value was significantly higher in Peer than in Antwerp, both in terms of crude data (p=0.011) and after correction for age, level of education, smoking status, serum level of selenium and body mass index through analysis of covariance (p=0.011). For the total study population, serum lead concentration showed a non-significant positive correlation with lnV sub(fpos). In addition, subjects with a blood lead concentration above the median tended to have higher V sub(fpos) values (9.45x10 super(-6) for 'high' group versus 5.21x10 super(-6) for 'low' group; p=0.077 after correction for confounding). Subjects with a serum selenium level above the median tended to have lower V sub(fpos) values (4.99x10 super(-6) for 'high' group versus 9.83x10 super(-6) for 'low' group; p=0.051 after correction for confounding). These data are consistent with an indirect genotoxic effect of lead and with an antimutagenic effect of selenium.
Author Van Larebeke, Nicolas
Koppen, Gudrun
Albering, Harma
Kleinjans, Jos
Riga, Louk
Vlietinck, Robert
Nelen, Vera
Van Loon, Herman
Schoeters, Greet
Author_xml – sequence: 1
  givenname: Nicolas
  surname: Van Larebeke
  fullname: Van Larebeke, Nicolas
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 2
  givenname: Gudrun
  surname: Koppen
  fullname: Koppen, Gudrun
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 3
  givenname: Vera
  surname: Nelen
  fullname: Nelen, Vera
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 4
  givenname: Greet
  surname: Schoeters
  fullname: Schoeters, Greet
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 5
  givenname: Herman
  surname: Van Loon
  fullname: Van Loon, Herman
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 6
  givenname: Harma
  surname: Albering
  fullname: Albering, Harma
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 7
  givenname: Louk
  surname: Riga
  fullname: Riga, Louk
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 8
  givenname: Robert
  surname: Vlietinck
  fullname: Vlietinck, Robert
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
– sequence: 9
  givenname: Jos
  surname: Kleinjans
  fullname: Kleinjans, Jos
  email: nicolas.vanlarebeke@ugent.be
  organization: Study Centre for Carcinogenesis and Primary Prevention of Cancer, Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, Ghent University Hospital, Belgium
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15677884$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15204312$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtv1DAUhS1URKeFf4CQN7AL2PErYQFCpaVIlUCorKOb-KbjyrGLnTCaHT-9CTMVDyG68V34O0fn3nNEDkIMSMhTzl5yVrFXXChpFGOCM8a4ViXX7AFZcalVIaSpDsiK1VoURlb6kBzlfL1wyphH5JCrkknByxX58d71PSYMHWbqAj3__OWSDtMIYaR9wm_T_LOlMMRwRQdnrccCrtDSM4-Dy2u6iQOGRQg5x87B6GKgGzeuKSQEGnuaMDu7-FMIlrY-Rks9wvJ8R58fk4c9-IxP9vOYfD07vTw5Ly4-ffh48u6i6OYtx8LWwFslJG-BG2ms0K2xShlrW9OhFn3Zgi7LugXAqq4l41BqJXSpKuxBMHFMXux8b1Kct8pjM-fv0HsIGKfccGPKistqBp_twakd0DY3yQ2Qts3dzWbg-R6A3IHvE4TO5d84bUxVyZmTO65LMeeE_S-ENUuFzb8qnGWv_5J1bvx51zGB8_eJ3-7ELvQxDbCJydtmhK2P6S6ouMfhzR8OawQ_rru5zeY6TinMHf0_wi1GY8Wq
CitedBy_id crossref_primary_10_1016_j_ijheh_2014_11_002
crossref_primary_10_1289_ehp_8811
crossref_primary_10_1093_carcin_bgv031
crossref_primary_10_1186_1476_069X_7_26
crossref_primary_10_1016_j_mrgentox_2005_09_007
crossref_primary_10_2164_jandrol_107_002626
Cites_doi 10.1016/S1383-5718(99)00120-5
10.1093/mutage/10.5.449
10.1016/0165-1218(92)90034-W
10.1289/ehp.02110325
10.1016/S0378-4274(01)00378-2
10.1289/ehp.02110583
10.1093/carcin/21.11.2097
10.1016/0165-7992(95)90043-8
10.1007/BF02784046
10.1002/1097-0274(200009)38:3<330::AID-AJIM13>3.0.CO;2-Z
10.1289/ehp.01109295
10.1016/S0027-5107(01)00075-6
10.1093/genetics/152.3.1065
10.1016/S0045-6535(02)00111-X
10.1002/1098-2744(199612)17:4<181::AID-MC2940170402>3.0.CO;2-F
10.1016/0378-4274(94)03200-9
10.1016/S1383-5718(02)00274-7
10.1002/1097-0274(200009)38:3<316::AID-AJIM11>3.0.CO;2-P
ContentType Journal Article
Copyright 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
2004 INIST-CNRS
Copyright_xml – notice: 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
– notice: 2004 INIST-CNRS
CorporateAuthor Flemish Environment and Health Study Group
CorporateAuthor_xml – name: Flemish Environment and Health Study Group
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T2
7U7
8FD
C1K
FR3
P64
RC3
DOI 10.1080/13547500310001652160
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Health and Safety Science Abstracts (Full archive)
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
Health & Safety Science Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList

MEDLINE
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Diet & Clinical Nutrition
Medicine
Biology
EISSN 1465-3478
1366-5804
EndPage 84
ExternalDocumentID 15204312
15677884
10_1080_13547500310001652160
11152606
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Belgium
Europe
GeographicLocations_xml – name: Belgium
GroupedDBID ---
-~X
00X
03L
0BK
0R~
29J
2QV
30N
36B
3EH
3V.
4.4
53G
5GY
5VS
7X2
7X7
88E
88I
8FE
8FH
8FI
8FJ
8G5
A8Z
AAAVI
AAGME
AAJMT
AALDU
AALIY
AAMIU
AAOAP
AAPUL
AAPXX
AAQRR
AAWTL
ABBKH
ABCCY
ABDBF
ABFIM
ABJVF
ABLIJ
ABLKL
ABPTK
ABQHQ
ABUWG
ABXUL
ACBBU
ACDHJ
ACFUF
ACGEJ
ACGFO
ACGFS
ACGOD
ACPRK
ACQMU
ACTIO
ACZPZ
ADBBV
ADCVX
ADFCX
ADGTB
ADGTR
ADNWM
ADOPC
ADRBQ
ADXPE
AEGYZ
AEISY
AENEX
AEOZL
AEPSL
AEYOC
AEYQI
AFDYB
AFKRA
AFKVX
AFRAH
AFWLO
AGDLA
AHDLD
AHMBA
AI.
AIAGR
AIJEM
AIRXU
AJWEG
AKBVH
AKOOK
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
APEBS
APNXG
AQRUH
ATCPS
AURDB
AWQZV
AWYRJ
AZQEC
BABNJ
BENPR
BFWEY
BHPHI
BKOMP
BLEHA
BPHCQ
BVXVI
CAG
CCCUG
COF
CS3
CWRZV
DGEBU
DKSSO
DU5
DWQXO
DXH
EAP
EAS
EBB
EBC
EBD
EBO
EBS
EBX
EHN
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
F5P
FAC
FAS
FJW
FYUFA
GNUQQ
GUQSH
H13
HCIFZ
HGUVV
HZ~
I-F
J.N
JEPSP
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M0K
M1P
M2O
M2P
M44
M4Z
O9-
OVD
OWHGL
P2P
PADUT
PCLFJ
PQEST
PQQKQ
PQUKI
PROAC
PSQYO
Q~Q
RNANH
ROSJB
RTWRZ
RWL
RXW
SV3
TAE
TEORI
TFDNU
TFL
TFT
TFW
TH9
TQWBC
TTHFI
TUS
UKHRP
V1S
VH1
WH7
Y6R
ZGOLN
~1N
~KM
23N
AAAVZ
AALUX
ABEIZ
ABJNI
ABOCM
ABUPF
ABXYU
ACENM
ACIEZ
ACKZS
ACUHS
ADFOM
ADFZZ
AECIN
AEIIZ
AGFJD
AGRBW
AGYJP
AIRBT
ALYBC
AMDAE
BOHLJ
CYYVM
CZDIS
DRXRE
DWTOO
EST
RVRKI
TBQAZ
TDBHL
TERGH
TUROJ
UEQFS
UHWXJ
AAGDL
AAORF
AAYXX
ABWCV
ABWVI
ABZEW
ACOPL
ACYZI
ADYSH
AFLEI
AFRVT
AJVHN
AMPGV
BRMBE
CITATION
JENTW
NUSFT
QQXMO
IQODW
TASJS
CGR
CUY
CVF
ECM
EIF
NPM
7T2
7U7
8FD
C1K
FR3
P64
RC3
ID FETCH-LOGICAL-c475t-d9a1b5341ba1747d36b7d557ddb7ce63f2ba6229baae899401a26536258efa303
ISSN 0963-7486
1354-750X
IngestDate Fri Jul 11 03:39:29 EDT 2025
Wed Feb 19 01:41:44 EST 2025
Mon Jul 21 09:14:33 EDT 2025
Thu Apr 24 22:56:45 EDT 2025
Tue Jul 01 02:04:13 EDT 2025
Wed Dec 25 09:05:19 EST 2024
Wed Jun 21 01:44:08 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Enzyme
Antimutagen
Toxicity
Transferases
Rate
Glycosyltransferases
Genotoxicity
Biological marker
mutant frequency
Hypoxanthine phosphoribosyltransferase
HPRT
pollution
Epidemiology
Heavy metal
Residential zone
Pollutant
Lead
Environment
Mutation
Selenium
Woman
Pentosyltransferases
Public health
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c475t-d9a1b5341ba1747d36b7d557ddb7ce63f2ba6229baae899401a26536258efa303
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 15204312
PQID 17728148
PQPubID 23462
PageCount 14
ParticipantIDs proquest_miscellaneous_17728148
pascalfrancis_primary_15677884
crossref_citationtrail_10_1080_13547500310001652160
crossref_primary_10_1080_13547500310001652160
informaworld_taylorfrancis_310_1080_13547500310001652160
pubmed_primary_15204312
informahealthcare_journals_10_1080_13547500310001652160
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-January-February
1/1/2004
2004-01-00
2004
2004 Jan-Feb
20040101
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – month: 01
  year: 2004
  text: 2004-January-February
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Biomarkers
PublicationTitleAlternate Biomarkers
PublicationYear 2004
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
References MICHALSKA J. (CIT0018) 1999; 445
VAGLENOV A. (CIT0028) 2001; 109
BRANDA R. F. (CIT0002) 1995; 346
JEMAL A. (CIT0013) 2002; 110
MERZENICH H. (CIT0017) 2001; 10
CIT0022
RESTREPO H. G. (CIT0023) 2000; 38
KOPPEN G. (CIT0014) 2001; 123
XU D. X (CIT0032) 2003; 534
CURRY J. (CIT0006) 1999; 152
COLE J. (CIT0004) 1995; 10
DOONMEZ H. (CIT0008) 1998; 61
SILBERGELD E. (CIT0026) 2000; 38
EL BAYOUMY, K (CIT0010) 2001; 475
KOPPEN G. (CIT0015) 2002; 48
FU J. Y (CIT0011) 1999; 12
ASMUSS M. (CIT0001) 2000; 21
NAWROT T. S. (CIT0019) 2002; 110
YANG J. L. (CIT0033) 1996; 17
CLAEYS E (CIT0003) 1992
COVACI A. (CIT0005) 2001; 52
ROY N. K (CIT0024) 1992; 298
References_xml – volume: 52
  start-page: 265
  year: 2001
  ident: CIT0005
  publication-title: Organohalogen Compounds
– volume: 445
  start-page: 139
  year: 1999
  ident: CIT0018
  publication-title: Mutation Research
  doi: 10.1016/S1383-5718(99)00120-5
– start-page: pp. 83
  year: 1992
  ident: CIT0003
  publication-title: Analytical quality control of cadmium and lead in blood and cadmium in urine: results of its implementation during a five-year epidemiological study
– volume: 10
  start-page: 449
  year: 1995
  ident: CIT0004
  publication-title: Mutagenesis
  doi: 10.1093/mutage/10.5.449
– volume: 298
  start-page: 97
  year: 1992
  ident: CIT0024
  publication-title: Mutation Research
  doi: 10.1016/0165-1218(92)90034-W
– volume: 110
  start-page: 325
  year: 2002
  ident: CIT0013
  publication-title: Environmental Health Perspectives
  doi: 10.1289/ehp.02110325
– volume: 123
  start-page: 59
  year: 2001
  ident: CIT0014
  publication-title: Toxicology Letters
  doi: 10.1016/S0378-4274(01)00378-2
– volume: 110
  start-page: 583
  year: 2002
  ident: CIT0019
  publication-title: Environmental Health Perspectives
  doi: 10.1289/ehp.02110583
– volume: 21
  start-page: 2097
  year: 2000
  ident: CIT0001
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/21.11.2097
– volume: 346
  start-page: 121
  year: 1995
  ident: CIT0002
  publication-title: Mutation Research
  doi: 10.1016/0165-7992(95)90043-8
– volume: 12
  start-page: 15
  year: 1999
  ident: CIT0011
  publication-title: Biomedical and Environmental Sciences
– volume: 61
  start-page: 105
  year: 1998
  ident: CIT0008
  publication-title: Biological Trace Elements Research
  doi: 10.1007/BF02784046
– volume: 38
  start-page: 330
  year: 2000
  ident: CIT0023
  publication-title: American Journal of Industrial Medicine
  doi: 10.1002/1097-0274(200009)38:3<330::AID-AJIM13>3.0.CO;2-Z
– volume: 109
  start-page: 295
  year: 2001
  ident: CIT0028
  publication-title: Environmental Health Perspectives
  doi: 10.1289/ehp.01109295
– volume: 475
  start-page: 123
  year: 2001
  ident: CIT0010
  publication-title: Mutation Research
  doi: 10.1016/S0027-5107(01)00075-6
– volume: 152
  start-page: 1065
  year: 1999
  ident: CIT0006
  publication-title: Genetics
  doi: 10.1093/genetics/152.3.1065
– volume: 48
  start-page: 811
  year: 2002
  ident: CIT0015
  publication-title: Chemosphere
  doi: 10.1016/S0045-6535(02)00111-X
– volume: 17
  start-page: 181
  year: 1996
  ident: CIT0033
  publication-title: Molecular Carcinogenesis
  doi: 10.1002/1098-2744(199612)17:4<181::AID-MC2940170402>3.0.CO;2-F
– ident: CIT0022
  doi: 10.1016/0378-4274(94)03200-9
– volume: 534
  start-page: 155
  year: 2003
  ident: CIT0032
  publication-title: Mutation Research
  doi: 10.1016/S1383-5718(02)00274-7
– volume: 10
  start-page: 515
  year: 2001
  ident: CIT0017
  publication-title: Cancer Epidemiology, Biomarkers and Prevention
– volume: 38
  start-page: 316
  year: 2000
  ident: CIT0026
  publication-title: American Journal of Industrial Medicine
  doi: 10.1002/1097-0274(200009)38:3<316::AID-AJIM11>3.0.CO;2-P
SSID ssj0001577
ssj0013298
Score 1.6935217
Snippet Biomarkers were measured in residents of Wilrijk and Hoboken, industrial suburbs of the city of Antwerp, and of Peer, a rural municipality in Flanders,...
SourceID proquest
pubmed
pascalfrancis
crossref
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 71
SubjectTerms Aged
Belgium
Biological and medical sciences
Chemical and industrial products toxicology. Toxic occupational diseases
environment
Environmental Exposure
Female
HPRT
Humans
Hypoxanthine Phosphoribosyltransferase - genetics
lead
Lead - blood
Lead Poisoning - diagnosis
Medical sciences
Metals and various inorganic compounds
Middle Aged
mutant frequency
Mutation
pollution
selenium
Surveys and Questionnaires
Toxicology
Title Differences in HPRT mutant frequency among middle-aged Flemish women in association with area of residence and blood lead levels
URI https://www.tandfonline.com/doi/abs/10.1080/13547500310001652160
https://www.ncbi.nlm.nih.gov/pubmed/15204312
https://www.proquest.com/docview/17728148
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFICt0gnECxrjVi7DD7xVgVycxH5saUYFW6lGNypeIqdJxCTaoq5BGk_8D_4s59hukq6FAi9pZdVulPPFPsc-F0Je2GniSTvhFi53FgsZszj3HAsWl1yEdmJ7AmOHTwZB_4y9HfvjRuNnzWupWCYvJ9-3xpX8j1ShDeSKUbL_INlyUGiA7yBfuIKE4fpXMu6Z6ibaq6rdH56O2tMC6wK384X2kb4y5YSmaiPCgtkjbYOsppjISGVfwI6ykpEJdgNVEtVIsMV10VF1xqCc3LHOBF6-6TzM1YnwxXyKrj7V6dB5Z9A-7pxG3ehdVEInq8Oj98NhpJwM3hTpoighHUTHuvk8W5RrBlYFiUDz_mDiakzY9mq7otqoHG3UDKlNu57PLNBdxvV5WWzgp-dYXbJltVqzreuAdpzEYWFUWx1iOAFoKrp2wXra7WvLYemkCJZtGHLObpA9F2wQu0n2Ot1e96h2SKVKLZc3v4rM5Parbf-8pvnsm7y4n0svv2u5ctFJV17Ce5rrh_V7C0hpQqN9cseYMLSjebxLGtnsgNzURU2vDsitE-OucY_8qAFKL2YUAaUaUFoCShWgtAYoNYBSBSh2rAFKEVCKgNJ5TktAKQBKFaAUAaUa0Pvk7Cgave5bpuSHNYHntbRSIZ3EB80qkWAqh6kXJGHq-2GaJuEkC7zcTWTguiKRMuNCMNuRbuCDEubzLJegjj0gzdl8lj0i1GYpGAcT4bEcdGwRyIAJH70ApJCp4F6LeCtxxBOTDx_LsnyJHZM2d5sQW8Qqe33V-WB2_D7ckHRsppDLHT15nYd4qd4fQ0Ps_bnr4Ro71Z0apFvk-QqmGOSJZ4Ryls0LuCMgnTuMt8hDzVitL4bRO-7jXYM_Ibe1exvuUz4lzeWiyJ6B5r5MDs0bhJ_93qePvwAKbuan
linkProvider EBSCOhost
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF6h9gAXWloeLqWdA-K2xfZ61_axaqkCtBFCqcTN2vWu1aqJgxIHqZz46Z19OH1AqQSXHKJM5F1_nm9mPPsNIW9jrZiMVUEt3dEszzJaFCyhSC5NmccqZqU9O3wyFIPT7NM33ncTzkNbpc2hGy8U4Xy1fbhtMbpviXufMJ4h08WuOJ0IZCCBWfsqMlNq8y8WD5fOOOFu-CIG6szKZor-9Nw9_3KLndaDdunZshPrjp6pbaSUc9zLxg_BuD9KdWx1tEZUv07fpHKxt-jUXv3zjgTkf23EOnkaYlnY9-B7Rh6ZdoNs7reYx08u4R247lJXtt8g0eG56fC7oEM6hmE_BmCT_DoMU1rQZ8F5C4MvX0cwWdj5xtDMfK_3JbixSDBxBRWKXlADYg5RegZORcIaymusgS0wA26mhGkDMzP3w1MB1wquWR_GiG78-IHBwXNyevRhdDCgYTIErXG9HdWlTBRHAlYSM6pcM6FyzXmutcprI1iTKinStFRSGkwoMYeUqeDI1bwwjUTWfkFW2mlrXhGIM40xZF2yrMFQrBRSYMpoXxbLUuqyYBFhPSKqOsim2-kd4yoJ6qp_ugkRoUur71425IHf57-BrQreZP6AZXETklXnCj0BkBX7u-nOLfheXym3soJFFpHdHs8V3k_7Kkm2ZrrAK8KkrMBMOiIvPcxv2NrT1km69c8r2iWPB6OT4-r44_Dza_LEt0rZmtc2WelmC_MGo8BO7bjn_AofSkjc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQkRAXKC2P8GjngLilJHHsJMeKZbW8VhVqpd4iO7bVit1stZut1J746Ywf2W4LpRJccogyUex8mVdmviHkbaIkFYksY2vu4rzI87gsaRqjcTFVkciEVrZ3-NuYj47yz8fseK2L35ZV2hjaeKIIp6vtx32mTF8R9z6lLEdDl7jcdMrRAHEM2u9z22BrmziS8UoXp8zNXkQ_nVrWTN43z91yl2vGaTNQl56sCrFu0JnaOkqxwK00fgbG7U6qM1bDx0T0y_Q1Kj_2lp3cay5vMED-zz5skkfBk4V9D70n5J5ut8j2fotR_PQC3oGrLXVJ-y0SDU51h-cCC-kExv0QgG3ycxBmtKDGgtMWRgffD2G6tNONwcx9pfcFuKFIMHXplBh1oAJEHGL0BByHhBUUV0gDm14G3EsBMwNzvfCjUwGXCq5UHyaIbTyco2vwlBwNPx5-GMVhLkTc4Hq7WFUilQzNrxQYTxWKclkoxgqlZNFoTk0mBc-ySgqhMZzECFJknKGlZqU2Am32M7LRzlr9gkCSK_Qgm4rmBh2xiguOAaP9VSwqoaqSRoT2gKibQJpuZ3dM6jRwq_7pJUQkXkmdedKQO64vfsNaHXTJ4g7Jch2RdefSPAGPNf276M419F49KbOkgmUekd0ezjW-T_sjSbR6tsQnwpCsxDg6Is89ytdkba91mr385xXtkgcHg2H99dP4yyvy0NdJ2YTXa7LRzZf6DbqAndxxX_kv7qNHiw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+HPRT+mutant+frequency+among+middle-aged+Flemish+women+in+association+with+area+of+residence+and+blood+lead+levels&rft.jtitle=Biomarkers&rft.au=VAN+LAREBEKE%2C+Nicolas&rft.au=KOPPEN%2C+Gudrun&rft.au=NELEN%2C+Vera&rft.au=SCHOETERS%2C+Greet&rft.date=2004&rft.pub=Taylor+%26+Francis&rft.issn=1354-750X&rft.volume=9&rft.issue=1&rft.spage=71&rft.epage=84&rft_id=info:doi/10.1080%2F13547500310001652160&rft.externalDBID=n%2Fa&rft.externalDocID=15677884
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0963-7486&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0963-7486&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0963-7486&client=summon